Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections

Dimpy P. Shah, Shashank S. Ghantoji, Ella J. Ariza-Heredia, Jharna N. Shah, Katia K. El Taoum, Pankil K. Shah, Lior Nesher, Chitra Hosing, Gabriela Rondon, Richard E. Champlin, Roy F. Chemaly

Producción científica: Articlerevisión exhaustiva

113 Citas (Scopus)


We developed an immunodeficiency scoring index for respiratory syncytial virus (ISI-RSV) infection, based on a cohort of 237 allogeneic hematopoietic cell transplant (allo-HCT) recipients, that can predict the risk of progression to lower respiratory tract infection (LRTI) and RSV-associated mortality. A weighted index was calculated using adjusted hazard ratios for immunodeficiency markers. Based on the ISI-RSV (range, 0-12), patients were stratified into low (0-2), moderate (3-6), and high (7-12) risk groups. A significant trend of increasing incidence of LRTI and RSV-associated mortality was observed as the risk increased from low to moderate to high (P < .001). Patients in the high-risk group had the greatest benefit of ribavirin-based therapy at the upper respiratory tract infection stage and the highest risk for progression to LRTI and death when antiviral therapy was not given (6.5 [95% confidence interval (CI), 1.8-23.6] and 8.1 [95% CI, 1.1-57.6], respectively). The ISI-RSV is designed to stratify allo-HCT recipients with RSV infection into groups according to their risk for progression to LRTI and RSVassociated mortality. Identification of high-risk groups using this index would distinguish patients who would benefit the most from antiviral therapy, mainly with aerosolized ribavirin. The ISI-RSV should be validated in a multiinstitutional study.

Idioma originalEnglish (US)
Páginas (desde-hasta)3263-3268
Número de páginas6
EstadoPublished - may 22 2014

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology


Profundice en los temas de investigación de 'Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections'. En conjunto forman una huella única.

Citar esto